[ad_1] The FDA is also expected to soon address the question of whether to allow emergency coronavirus vaccines for children under the age of 12. Last week, the agency fullyRead More
Tag: FDA
Two Top FDA Vaccine Regulators Set to Split at a Crucial Time
[ad_1] The FDA is also expected to soon address the question of whether to allow emergency coronavirus vaccines for children under the age of 12. Last week, the agency fullyRead More
FDA Fully Approves Pfizer Vaccine
[ad_1] Vaccination rates have been rising steadily in recent weeks as fears of the delta variant increase. Providers were managing Nearly 837,000 shots were fired per day last weekend, andRead More
Stocks rise broadly; Pfizer wins after FDA approves vaccine
[ad_1] Stocks rose solidly on Wall Street in Monday afternoon trading, prompting the S&P 500 to recoup last week’s losses and eclipse its all-time high. The benchmark index rose 1%Read More
FDA Approves GHB, a ‘History Rape’ Drug for Rare Sleep Disorder
[ad_1] On the black market, homemade GHB, also known as liquid ecstasy, goop, and G, can be purchased by the clamshell. $5 to $25. But Xyrem and Xywav’s night treatmentsRead More
FDA Targets Vaccine Booster Rate for Patients with Immunodeficiency
[ad_1] The Food and Drug Administration is stepping up efforts to allow extra doses of coronavirus vaccines for Americans with weakened immune systems; This is a change that reflects growingRead More
FDA Aims to Speed Up Extra Doses of Vaccines for Patients with Immunodeficiency
[ad_1] The Food and Drug Administration is stepping up efforts to allow extra doses of coronavirus vaccines for Americans with weakened immune systems; This is a change that reflects growingRead More
FDA Targets Early Approval of Pfizer Vaccine
[ad_1] WASHINGTON — With a new surge of Covid-19 infections plaguing much of the United States, the Food and Drug Administration has stepped up the timeline to fully approve Pfizer-BioNTech’sRead More
FDA Issues Rare Nerve Syndrome Warning to Johnson & Johnson
[ad_1] The database shows only one possible death of a Johnson & Johnson recipient vaccinated from Guillain-Barré syndrome. But the 57-year-old Delaware man has also suffered a heart attack andRead More
FDA to Add Rare Nerve Syndrome Warning to Johnson & Johnson
[ad_1] The Food and Drug Administration plans to warn that Johnson & Johnson’s coronavirus vaccine could lead to an increased risk of a rare neurological condition known as Guillain-Barré syndrome.Read More